Ausgabe 4/2017
Inhalt (18 Artikel)
- editorial
Revival of anti-angiogenic therapies in cancer—news on an old therapeutic concept
Andreas Pircher
- Open Access
- short review
Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update
Robin J. Young, Penella J. Woll
- Open Access
- review
Antiangiogenic therapy in breast cancer
Simon Peter Gampenrieder, Theresa Westphal, Richard Greil
- Open Access
- review
Antiangiogenic therapies in urogenital malignancies
Friederike Haidl, David Pfister, Axel Heidenreich, Isabel Heidegger
- Open Access
- short review
Novel concepts of antiangiogenic therapies in metastatic renal cell cancer
Renate Pichler, Isabel Heidegger
- Open Access
- short review
Update on squamous cell carcinoma of the head and neck
Teresa Magnes, Alexander Egle, Richard Greil, Thomas Melchardt
- short review
ASCO update – what is new in the systemic treatment of advanced soft tissue sarcomas?
Joanna Szkandera
- Open Access
- short review
ASCO 2017—highlights of gynecological cancer
Bianca Radl, Brigitte Mlineritsch
- Open Access
- short review
ASCO-update: gastrointestinal tumors
Lukas Weiss, Florian Huemer, Richard Greil
- Open Access
- short review
Next generation sequencing: clinical applications in solid tumours
Leonhard Müllauer
- Open Access
- short review
Aggressive lymphoma 2016: revision of the WHO classification
Christine Beham-Schmid
- special report
The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling
Andreas Seeber, Günther Gastl, Wolfgang Eisterer, Simon P. Gampenrieder, Armin Gerger, Markus Kieler, Martin Pichler, Gerald W. Prager, Gerold Untergasser, Ansgar Weltermann, Richard Greil
- original report
Clinicopathological profile and treatment outcome of squamous cell carcinoma breast at a tertiary cancer center in South India
A. H. Rudresha, Abhishek Anand, K. C. Lakshmaiah, K. Govind Babu, D. Lokanatha, Amirtham Usha, Linu Abraham Jacob, Suresh Babu, K. N. Lokesh, L. K. Rajeev, Deepak Koppaka